These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Warfarin resistance: diagnosis and therapeutic alternatives. Hulse ML Pharmacotherapy; 1996; 16(6):1009-17. PubMed ID: 8947972 [TBL] [Abstract][Full Text] [Related]
6. Oral anticoagulants--the totem and the taboo. Breckenridge A Br Med J; 1976 Feb; 1(6007):419-23. PubMed ID: 766893 [No Abstract] [Full Text] [Related]
7. What to do when warfarin therapy goes too far. Prasad S; Wootten MR; Kulinski N; Chapman SA J Fam Pract; 2009 Jul; 58(7):346-52. PubMed ID: 19607771 [TBL] [Abstract][Full Text] [Related]
8. Anticipating drug response. A commonly used anticoalgulant has many drug-drug interactions. Lilley LL; Guanci R Am J Nurs; 1998 Sep; 98(9):12. PubMed ID: 9739740 [No Abstract] [Full Text] [Related]
9. Vitamin K intake and sensitivity to warfarin in patients consuming regular diets. Lubetsky A; Dekel-Stern E; Chetrit A; Lubin F; Halkin H Thromb Haemost; 1999 Mar; 81(3):396-9. PubMed ID: 10102468 [TBL] [Abstract][Full Text] [Related]
11. Control of bleeding in splenectomized and coumadin treated animals: potentiation of ellagic acid effect with vitamin K. Agostino D; Cliffton EE Nagoya Med J; 1968 Apr; 14(1):65-73. PubMed ID: 5696331 [No Abstract] [Full Text] [Related]
12. Liquid nutrition as a cause of warfarin resistance. Zallman JA; Lee DP; Jeffrey PL Am J Hosp Pharm; 1981 Aug; 38(8):1174. PubMed ID: 7270565 [No Abstract] [Full Text] [Related]
13. Effects of warfarin, phenylindanedione, tetrachloropyridinol, and chloro-vitamin K1 on prothrombin synthesis and vitamin K metabolism in normal and warfarin-resistant rats. Ren P; Laliberte RE; Bell RG Mol Pharmacol; 1974 May; 10(3):373-80. PubMed ID: 4851787 [No Abstract] [Full Text] [Related]
14. Vitamin K and thrombosis. Merli GJ; Fink J Vitam Horm; 2008; 78():265-79. PubMed ID: 18374199 [TBL] [Abstract][Full Text] [Related]
15. Anticoagulants: the state of the art. Gallus AS Aust Fam Physician; 1982 Jan; 11(1):14-22. PubMed ID: 7065989 [TBL] [Abstract][Full Text] [Related]
16. The influence of (R)- and (S)-warfarin, vitamin K and vitamin K epoxide upon warfarin anticoagulation. Kamali F; Edwards C; Butler TJ; Wynne HA Thromb Haemost; 2000 Jul; 84(1):39-42. PubMed ID: 10928467 [TBL] [Abstract][Full Text] [Related]
18. The relationship between maintenance dosages of three vitamin K antagonists: acenocoumarol, warfarin and phenprocoumon. van Leeuwen Y; Rosendaal FR; van der Meer FJ Thromb Res; 2008; 123(2):225-30. PubMed ID: 18407321 [TBL] [Abstract][Full Text] [Related]
19. Warfarin pharmacology, clinical management, and evaluation of hemorrhagic risk for the elderly. Jacobs LG Cardiol Clin; 2008 May; 26(2):157-67, v. PubMed ID: 18406992 [TBL] [Abstract][Full Text] [Related]
20. Developmental changes in pharmacokinetics and pharmacodynamics of warfarin enantiomers in Japanese children. Takahashi H; Ishikawa S; Nomoto S; Nishigaki Y; Ando F; Kashima T; Kimura S; Kanamori M; Echizen H Clin Pharmacol Ther; 2000 Nov; 68(5):541-55. PubMed ID: 11103757 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]